Gilead’s remdesivir could see $7 billion in annual sales on stockpiling boost: analyst

June 3, 2020 admin Business News Comments Off on Gilead’s remdesivir could see $7 billion in annual sales on stockpiling boost: analyst

Gilead Sciences Inc’s potential COVID-19 treatment, remdesivir, could bring in more than $7 billion in annual sales by 2022, spurred by governments stockpiling the drug to guard against future outbreaks, SVB Leerink said on Wednesday.

…read more

Get our FREE Newsletter! Discover Stocks with +1,000% Upside Potential!
Join over 100,000 investors and business leaders worldwide. Discover the Next Super Stock before the rest of the crowd.
Your privacy is our priority. Your email address will never be sold or shared with anyone else.

Source:: Reuters – Business News